BIOMAT Database Logo BIOMAT Database Logo

Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis. 2006

Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Department of Laboratory Medicine, University of Washington, Seattle, WA 98195-7110, USA. limaye@u.washington.edu

BACKGROUND Antiviral prophylaxis has been shown to decrease the incidence of cytomegalovirus (CMV) disease in organ transplant recipients, but whether CMV disease that occurs despite prophylaxis is associated with mortality remains unknown. METHODS The clinical features and risk factors for CMV disease in a cohort of liver transplant recipients who received antiviral prophylaxis were assessed retrospectively. Cox proportional hazard regression was used to assess the relationship of CMV to mortality during the first posttransplant year. RESULTS CMV disease developed in 37 of 437 (8.5%) recipients at a median of 4.5 (range, 2.5 to 12) months posttransplant and was associated only with donor-seropositive/recipient-seronegative serostatus in multivariate analysis (P<0.0001). Mortality at 1 year was 12% (51 of 437) and was infection-associated in 49% of cases. In multivariate analysis, CMV disease was independently associated with overall mortality at 1 year (HR, 5.1, P=0.002) and even more strongly with infection-associated mortality (HR 11, P=0.002). There was no association of CMV with noninfection-associated mortality (P>0.05). CONCLUSIONS Late CMV disease is an important clinical problem in liver transplant recipients who receive antiviral prophylaxis, and is strongly and independently associated with mortality. Strategies to prevent late CMV disease are warranted.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence

Related Publications

Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Cytomegalovirus prophylaxis in solid organ transplant recipients.
May 1996, Transplantation,
Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients.
July 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Antiviral dosing and efficacy for prophylaxis of cytomegalovirus disease in solid organ transplant recipients.
October 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Cytomegalovirus prophylaxis in solid organ transplant recipients: the issues.
March 2000, Transplantation proceedings,
Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients.
September 2011, Transplant international : official journal of the European Society for Organ Transplantation,
Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Impact of High-Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients.
July 2018, Pharmacotherapy,
Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Impact of cytomegalovirus infection on organ transplant recipients.
January 1990, Reviews of infectious diseases,
Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.
April 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
December 2002, Seminars in respiratory infections,
Ajit P Limaye, and Ramasamy Bakthavatsalam, and Hyung W Kim, and Sara E Randolph, and Jeffrey B Halldorson, and Patrick J Healey, and Christian S Kuhr, and Adam E Levy, and James D Perkins, and Jorge D Reyes, and Michael Boeckh
Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients.
November 2011, Transplantation,
Copied contents to your clipboard!